Cargando…
COPD phenotype description using principal components analysis
BACKGROUND: Airway inflammation in COPD can be measured using biomarkers such as induced sputum and Fe(NO). This study set out to explore the heterogeneity of COPD using biomarkers of airway and systemic inflammation and pulmonary function by principal components analysis (PCA). SUBJECTS AND METHODS...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698901/ https://www.ncbi.nlm.nih.gov/pubmed/19480658 http://dx.doi.org/10.1186/1465-9921-10-41 |
_version_ | 1782168433937350656 |
---|---|
author | Roy, Kay Smith, Jacky Kolsum, Umme Borrill, Zöe Vestbo, Jørgen Singh, Dave |
author_facet | Roy, Kay Smith, Jacky Kolsum, Umme Borrill, Zöe Vestbo, Jørgen Singh, Dave |
author_sort | Roy, Kay |
collection | PubMed |
description | BACKGROUND: Airway inflammation in COPD can be measured using biomarkers such as induced sputum and Fe(NO). This study set out to explore the heterogeneity of COPD using biomarkers of airway and systemic inflammation and pulmonary function by principal components analysis (PCA). SUBJECTS AND METHODS: In 127 COPD patients (mean FEV(1 )61%), pulmonary function, Fe(NO), plasma CRP and TNF-α, sputum differential cell counts and sputum IL8 (pg/ml) were measured. Principal components analysis as well as multivariate analysis was performed. RESULTS: PCA identified four main components (% variance): (1) sputum neutrophil cell count and supernatant IL8 and plasma TNF-α (20.2%), (2) Sputum eosinophils % and Fe(NO )(18.2%), (3) Bronchodilator reversibility, FEV(1 )and IC (15.1%) and (4) CRP (11.4%). These results were confirmed by linear regression multivariate analyses which showed strong associations between the variables within components 1 and 2. CONCLUSION: COPD is a multi dimensional disease. Unrelated components of disease were identified, including neutrophilic airway inflammation which was associated with systemic inflammation, and sputum eosinophils which were related to increased Fe(NO). We confirm dissociation between airway inflammation and lung function in this cohort of patients. |
format | Text |
id | pubmed-2698901 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26989012009-06-19 COPD phenotype description using principal components analysis Roy, Kay Smith, Jacky Kolsum, Umme Borrill, Zöe Vestbo, Jørgen Singh, Dave Respir Res Research BACKGROUND: Airway inflammation in COPD can be measured using biomarkers such as induced sputum and Fe(NO). This study set out to explore the heterogeneity of COPD using biomarkers of airway and systemic inflammation and pulmonary function by principal components analysis (PCA). SUBJECTS AND METHODS: In 127 COPD patients (mean FEV(1 )61%), pulmonary function, Fe(NO), plasma CRP and TNF-α, sputum differential cell counts and sputum IL8 (pg/ml) were measured. Principal components analysis as well as multivariate analysis was performed. RESULTS: PCA identified four main components (% variance): (1) sputum neutrophil cell count and supernatant IL8 and plasma TNF-α (20.2%), (2) Sputum eosinophils % and Fe(NO )(18.2%), (3) Bronchodilator reversibility, FEV(1 )and IC (15.1%) and (4) CRP (11.4%). These results were confirmed by linear regression multivariate analyses which showed strong associations between the variables within components 1 and 2. CONCLUSION: COPD is a multi dimensional disease. Unrelated components of disease were identified, including neutrophilic airway inflammation which was associated with systemic inflammation, and sputum eosinophils which were related to increased Fe(NO). We confirm dissociation between airway inflammation and lung function in this cohort of patients. BioMed Central 2009 2009-05-29 /pmc/articles/PMC2698901/ /pubmed/19480658 http://dx.doi.org/10.1186/1465-9921-10-41 Text en Copyright © 2009 Roy et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Roy, Kay Smith, Jacky Kolsum, Umme Borrill, Zöe Vestbo, Jørgen Singh, Dave COPD phenotype description using principal components analysis |
title | COPD phenotype description using principal components analysis |
title_full | COPD phenotype description using principal components analysis |
title_fullStr | COPD phenotype description using principal components analysis |
title_full_unstemmed | COPD phenotype description using principal components analysis |
title_short | COPD phenotype description using principal components analysis |
title_sort | copd phenotype description using principal components analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698901/ https://www.ncbi.nlm.nih.gov/pubmed/19480658 http://dx.doi.org/10.1186/1465-9921-10-41 |
work_keys_str_mv | AT roykay copdphenotypedescriptionusingprincipalcomponentsanalysis AT smithjacky copdphenotypedescriptionusingprincipalcomponentsanalysis AT kolsumumme copdphenotypedescriptionusingprincipalcomponentsanalysis AT borrillzoe copdphenotypedescriptionusingprincipalcomponentsanalysis AT vestbojørgen copdphenotypedescriptionusingprincipalcomponentsanalysis AT singhdave copdphenotypedescriptionusingprincipalcomponentsanalysis |